Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Diabetic Macular Edema Treated with Anti–Vascular Endothelial Growth Factor: Considerations Related to Nonimprovers

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Evaluating an algorithm for screening intervals for diabetic retinopathy and the effect of HbA1c and hypertension

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  2. Assessment of diurnal melatonin, cortisol, activity, and sleep-wake cycle in patients with and without diabetic retinopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. DEEP LEARNING FOR CLASSIFICATION OF TYPES OF RETINAL FUNDUS IMAGES

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  4. Incidence of diabetic eye disease among migrants: a cohort study of 100,000 adults with diabetes in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Purpose To investigate central subfield thickness (CST) nonimprovers’ anatomic response in macular areas outside the central subfield and the time course of this response. Furthermore, to investigate the relationship between peripheral improvement and visual acuity. Design Retrospective study. Participants A total of 566 eyes in 566 patients with center-involved diabetic macular edema who initiated intravitreal treatment with ranibizumab between January 1, 2011 and December 31, 2013 in the Greater Copenhagen Region. Follow-up was completed at 2 years. Methods Patients were initially grouped as CST improvers and CST nonimprovers. The CST improvers had a ≥10% reduction in CST on ≥1 visit as opposed to CST nonimprovers with
OriginalsprogEngelsk
TidsskriftOphthalmology Retina
Vol/bind2
Udgave nummer11
Sider (fra-til)1133-1142
Antal sider10
ISSN2468-6530
DOI
StatusUdgivet - nov. 2018

ID: 55656624